The role of ADAMTS-13 and von Willebrand factor in cancer patients: Results from the Vienna Cancer and Thrombosis Study.

Hanna L ObermeierJulia RiedlCihan AySilvia KoderPeter QuehenbergerRupert BartschAlexandra KaiderChristoph C ZielinskiIngrid Pabinger

Published in: Research and practice in thrombosis and haemostasis (2019)

High VWF levels were significantly associated with the risk of developing VTE in cancer patients, whereas ADAMTS-13 was not. Low ADAMTS-13 and increased VWF levels were independently associated with worse overall survival.

Keyphrases

venous thromboembolism
papillary thyroid
pulmonary embolism
squamous cell
young adults